United States
US 12,702,721 B2
Gene therapy for macular degeneration
US 12,702,721 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATION. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- UNIVERSITY OF UTAH RESEARCH FOUNDATION
- Inventors
- Gregory Scott HAGEMAN; Burt Timothy RICHARDS
- Publication date
- 2026-08-11
- Filing date
- 2021-01-19
- Document type
- B2 Granted patent
- Also written as
- US 12,702,721 B2 · US12702721 · 12702721
Abstract
The invention provides compositions and methods for treatment of age-related macular degeneration, including gene therapy employing vectors and transgenes expressing protective CFH polypeptide and CFHT polypeptide sequences.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free